Name: LSBWF Balance Sheet - Lakeshore Biopharma Co. Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LSBWF - Lakeshore Biopharma Co. Ltd.

USD | OTC Markets | Healthcare

LSBWF Balance Sheet - Lakeshore Biopharma Co. Assets & Debt | Ledgeburg

(in millions of USD)	Q4 FY 25	Q4 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	-	-	53.9
Restricted Cash	11.1	0.0	0.0
Short Term Investments	-	-	-
Cash And Short Term Investments	-	-	53.9
Receivables
Accounts Receivable	69.8	62.6	67.4
Current Assets
Inventory	31.7	28.7	27.0
Prepaid Expenses	0.6	1.0	1.5
Other Current Assets	-	-	0.1
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	102.1	111.2	113.6
Accumulated Depreciation	26.7	29.0	26.0
Property,Plant & Equipment Net	57.6	66.7	83.2
Long Term Investments
Current Liabilities
Accounts Payable	6.9	9.6	11.7
Short Term Debt	54.4	44.9	28.2
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	3.3	14.0	42.8
Operating Lease Liabilities Non-Current	-	0.3	0.9
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	0.0
Additional Paid In Capital	-	-	386.6
Retained Earnings	(335.4)	(325.2)	(272.7)
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	57.7	58.8	70.9
Net debt	-	-	17.0
Working Capital	2.4	14.2	54.9
Book Value	69.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	-	-	53.9
Restricted Cash	11.1	0.0	0.0
Short Term Investments	-	-	-
Cash And Short Term Investments	-	-	53.9
Receivables
Accounts Receivable	69.8	62.6	67.4
Current Assets
Inventory	31.7	28.7	27.0
Prepaid Expenses	0.6	1.0	1.5
Other Current Assets	-	-	0.1
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	102.1	111.2	113.6
Accumulated Depreciation	26.7	29.0	26.0
Property,Plant & Equipment Net	57.6	66.7	83.2
Long Term Investments
Current Liabilities
Accounts Payable	6.9	9.6	11.7
Short Term Debt	54.4	44.9	28.2
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	3.3	14.0	42.8
Operating Lease Liabilities Non-Current	-	0.3	0.9
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	0.0
Additional Paid In Capital	-	-	386.6
Retained Earnings	(335.4)	(325.2)	(272.7)
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	57.7	58.8	70.9
Net debt	-	-	17.0
Working Capital	2.4	14.2	54.9
Book Value	69.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)